Matthew T Chin, MD
Internal Medicine · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 059546 · 757662 · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chin’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A153472 · Current
Licensed to practise in California · since 2018 · expires 2027-11-30 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$141,727
Medicare paid this office $141,727 for 515 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 248 | $40,370 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 241 | $37,766 | $157 |
| Short return visit (20+ min) | 257 | $27,483 | $77 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 26 | $7,548 | $290 |
| Transitional care management services for problem of at least moderate complexity | 32 | $7,258 | $196 |
See all 13 services
| Return visit (30+ min) | 248 | $40,370 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 241 | $37,766 | $157 |
| Short return visit (20+ min) | 257 | $27,483 | $77 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 26 | $7,548 | $290 |
| Transitional care management services for problem of at least moderate complexity | 32 | $7,258 | $196 |
| Long return visit (40+ min) | 30 | $6,366 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,489 | $152 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 14 | $2,777 | $198 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 98 | $1,718 | $14 |
| Administration of pneumococcal vaccine | 29 | $1,052 | $36 |
| Influenza vaccine, inactivated | 12 | $982 | $82 |
| Administration of influenza virus vaccine | 13 | $508 | $39 |
| Removal of impacted ear wax by washing | 20 | $323 | $16 |
Who their Medicare patients are
515 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 18% · Women 31% · Also on Medicaid 5% · Health risk score 1.04. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 61% · Coronary heart disease 24% · Diabetes 23% · Chronic kidney disease 22% · Atrial fibrillation 18% · Cancer 17% · Depression 13% · Heart failure 11% · Dementia 8% · COPD 7% · Stroke 7%.
The office billed $377,697, Medicare allowed $175,335 and paid $141,727; for 1,356 services of 38 kinds; $9,929 of it was for drugs given in the office and $131,798 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 515 | 1,356 | 77 | 1.04 | $377,697 | $141,727 |
| 2023 | 534 | 1,227 | 77 | 1.02 | $358,553 | $136,633 |
| 2022 | 499 | 1,638 | 76 | 0.98 | $333,955 | $136,534 |
| 2021 | 372 | 2,188 | 77 | 1.06 | $189,086 | $78,420 |
| 2020 | 260 | 843 | 77 | 1.20 | $122,122 | $46,380 |
| 2019 | 53 | 86 | 79 | 0.98 | $23,797 | $8,683 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 275 | $48,186 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 231 | $36,854 | $160 |
| Short return visit (20+ min) | 273 | $25,879 | $73 |
| Transitional care management services for problem of at least moderate complexity | 33 | $8,559 | $204 |
| Long return visit (40+ min) | 36 | $6,758 | $161 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 14 | $3,378 | $241 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,223 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,919 | $148 |
| Administration of pneumococcal vaccine | 15 | $527 | $35 |
2022: 12 services
| Return visit (30+ min) | 264 | $48,905 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 213 | $33,704 | $158 |
| Short return visit (20+ min) | 252 | $25,466 | $74 |
| Long return visit (40+ min) | 30 | $5,279 | $160 |
| Transitional care management services for problem of at least moderate complexity | 20 | $4,446 | $202 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 17 | $3,453 | $203 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 13 | $3,146 | $242 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,197 | $157 |
| Pneumococcal vaccine, 23-valent | 16 | $2,117 | $132 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,194 | $70 |
| Administration of pneumococcal vaccine | 30 | $1,022 | $34 |
| Administration of influenza virus vaccine | 18 | $680 | $38 |
2021: 11 services
| Return visit (30+ min) | 156 | $20,165 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 136 | $19,806 | $146 |
| Short return visit (20+ min) | 150 | $16,226 | $78 |
| Transitional care management services for problem of at least moderate complexity | 16 | $3,288 | $206 |
| Long return visit (40+ min) | 23 | $2,975 | $124 |
| Pneumococcal vaccine, 23-valent | 17 | $2,123 | $125 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,590 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,505 | $116 |
| Influenza vaccine split virus, preservative free | 22 | $1,436 | $65 |
| Administration of influenza virus vaccine | 22 | $481 | $22 |
| Administration of pneumococcal vaccine | 19 | $412 | $22 |
2020: 11 services
| Return visit (30+ min) | 123 | $14,080 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $6,552 | $139 |
| Short return visit (20+ min) | 79 | $6,319 | $63 |
| Pneumococcal vaccine, 13-valent | 16 | $3,563 | $223 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $2,537 | $75 |
| New patient visit (30+ min) | 31 | $2,294 | $74 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,634 | $126 |
| Influenza vaccine split virus, preservative free | 21 | $1,274 | $61 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $676 | $42 |
| Administration of pneumococcal vaccine | 25 | $520 | $21 |
| Administration of influenza virus vaccine | 21 | $439 | $21 |
2019: 1 service
| Return visit (30+ min) | 32 | $3,394 | $97 |
Drugs they prescribed that Part D paid
$401,072
Pharmacies billed $401,072 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (108 of 5,522) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
5,043 generic and 458 brand-name prescriptions · $401,072 in drug cost · 143 antibiotic prescriptions to 87 people · 20 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 47 | $74,971 | $1,595 |
| Eliquis | 45 | $58,353 | $1,297 |
| Mounjaro | 22 | $31,282 | $1,422 |
| Januvia | 23 | $24,752 | $1,076 |
| Xarelto | 11 | $15,525 | $1,411 |
See all 104 drugs
| Jardiance | 47 | $74,971 | $1,595 |
| Eliquis | 45 | $58,353 | $1,297 |
| Mounjaro | 22 | $31,282 | $1,422 |
| Januvia | 23 | $24,752 | $1,076 |
| Xarelto | 11 | $15,525 | $1,411 |
| Atorvastatin | 412 | $4,536 | $11 |
| Carbidopa-Levodopa | 33 | $3,735 | $113 |
| Dexlansoprazole Dr | 12 | $3,282 | $274 |
| Tamsulosin | 160 | $3,059 | $19 |
| Losartan | 218 | $2,641 | $12 |
| Arnuity Ellipta | 13 | $2,347 | $181 |
| Rosuvastatin | 165 | $2,344 | $14 |
| Amlodipine Besylate | 293 | $2,144 | $7 |
| Levothyroxine | 141 | $2,020 | $14 |
| Lisinopril | 188 | $1,662 | $9 |
| Gabapentin | 107 | $1,584 | $15 |
| Diclofenac | 14 | $1,465 | $105 |
| Metoprolol | 90 | $1,358 | $15 |
| Hydrocodone-Acetaminophen | 58 | $1,333 | $23 |
| Pantoprazole | 107 | $1,332 | $12 |
| Metformin | 135 | $1,329 | $10 |
| Donepezil | 97 | $1,261 | $13 |
| Potassium Chloride | 34 | $1,261 | $37 |
| Zolpidem | 112 | $1,244 | $11 |
| Synthroid | 13 | $1,223 | $94 |
| Colchicine | 25 | $1,220 | $49 |
| Omeprazole | 71 | $1,193 | $17 |
| Metformin Hcl Er | 85 | $1,178 | $14 |
| Allopurinol | 86 | $1,159 | $13 |
| Valacyclovir | 24 | $1,148 | $48 |
| Fluticasone Propionate | 54 | $1,110 | $21 |
| Famotidine | 32 | $1,098 | $34 |
| Nebivolol | 12 | $1,071 | $89 |
| Trazodone | 84 | $1,049 | $12 |
| Nano 2nd Gen Pen Needle | 13 | $971 | $75 |
| Simvastatin | 97 | $910 | $9 |
| Pravastatin | 63 | $871 | $14 |
| Celecoxib | 13 | $853 | $66 |
| Bupropion Xl | 24 | $840 | $35 |
| Lactulose | 29 | $808 | $28 |
| Sertraline | 51 | $775 | $15 |
| Valsartan | 19 | $708 | $37 |
| Olmesartan Medoxomil | 41 | $706 | $17 |
| Ezetimibe | 19 | $678 | $36 |
| Finasteride | 35 | $613 | $18 |
| Alendronate | 53 | $608 | $11 |
| Atenolol | 63 | $601 | $10 |
| Benazepril | 52 | $582 | $11 |
| Oxycodone-Acetaminophen | 11 | $576 | $52 |
| Hydrochlorothiazide | 92 | $560 | $6 |
| Diltiazem 24hr Er (Cd) | 16 | $557 | $35 |
| Quetiapine | 19 | $528 | $28 |
| Escitalopram | 41 | $456 | $11 |
| Lovastatin | 48 | $448 | $9 |
| Digoxin | 12 | $446 | $37 |
| Albuterol Sulfate Hfa | 29 | $433 | $15 |
| Carbidopa-Levodopa Er | 11 | $425 | $39 |
| Lorazepam | 25 | $412 | $16 |
| Triamcinolone Acetonide | 38 | $401 | $11 |
| Oxybutynin Chloride Er | 13 | $382 | $29 |
| Doxazosin Mesylate | 15 | $375 | $25 |
| Propranolol | 18 | $368 | $20 |
| Hydrocortisone | 19 | $352 | $19 |
| Mirtazapine | 23 | $350 | $15 |
| Valsartan-Hydrochlorothiazide | 13 | $345 | $27 |
| Prednisone | 38 | $343 | $9 |
| Terazosin | 16 | $340 | $21 |
| Citalopram Hbr | 31 | $324 | $10 |
| Clopidogrel | 30 | $319 | $11 |
| Latanoprost | 15 | $304 | $20 |
| Buspirone | 15 | $292 | $19 |
| Spironolactone | 16 | $289 | $18 |
| Losartan-Hydrochlorothiazide | 23 | $285 | $12 |
| Glipizide Er | 22 | $265 | $12 |
| Lisinopril-Hydrochlorothiazide | 35 | $265 | $8 |
| Furosemide | 56 | $264 | $5 |
| Ciclopirox | 14 | $264 | $19 |
| Nitrofurantoin Mono-Macro | 20 | $257 | $13 |
| Lamotrigine | 11 | $205 | $19 |
| Sildenafil Citrate | 18 | $194 | $11 |
| Fluoxetine | 36 | $169 | $5 |
| Naproxen | 20 | $167 | $8 |
| Metoprolol | 26 | $164 | $6 |
| Pioglitazone | 15 | $161 | $11 |
| Hydromorphone | 12 | $158 | $13 |
| Montelukast | 16 | $156 | $10 |
| Meloxicam | 37 | $152 | $4 |
| Carvedilol | 21 | $145 | $7 |
| Nystatin | 11 | $142 | $13 |
| Hydroxyzine | 16 | $140 | $9 |
| Cephalexin | 22 | $138 | $6 |
| Glipizide | 19 | $138 | $7 |
| Amoxicillin-Clavulanate Potass | 24 | $132 | $5 |
| Azithromycin | 35 | $118 | $3 |
| Calcitriol | 12 | $109 | $9 |
| Sulfamethoxazole-Trimethoprim | 12 | $106 | $9 |
| Tramadol | 18 | $97 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $94 | $9 |
| Cyclobenzaprine | 19 | $74 | $4 |
| Clonazepam | 16 | $45 | $3 |
| Eszopiclone | 12 | $45 | $4 |
| Glimepiride | 11 | $40 | $4 |
| Alprazolam | 21 | $24 | $1 |
| Paxlovid | 19 | $0 | $0 |
Year by year
| 2024 | 5,522 | 567 | 2% (108) | 8% | $401,072 |
| 2023 | 4,713 | 541 | 2% (114) | 7% | $350,124 |
| 2022 | 3,846 | 469 | 2% (84) | 8% | $295,336 |
| 2021 | 2,400 | 351 | 5% (109) | 7% | $145,261 |
| 2020 | 1,074 | 181 | 10% (106) | None | $106,972 |
| 2019 | 104 | 40 | 0% (0) | None | $18,735 |
| 2018 | 85 | 22 | 0% (0) | None | $4,673 |
| 2017 | 53 | 23 | 0% (0) | None | $3,590 |
| 2016 | 19 | 11 | 0% (0) | None | $758 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 97 drugs
| Jardiance | 35 | $51,436 | $1,470 |
| Eliquis | 31 | $47,534 | $1,533 |
| Januvia | 17 | $23,595 | $1,388 |
| Xarelto | 11 | $16,778 | $1,525 |
| Atorvastatin | 366 | $4,349 | $12 |
| Flovent Hfa | 11 | $4,214 | $383 |
| Losartan | 178 | $3,281 | $18 |
| Rosuvastatin | 122 | $3,108 | $25 |
| Tamsulosin | 133 | $3,036 | $23 |
| Amlodipine Besylate | 255 | $2,558 | $10 |
| Carbidopa-Levodopa | 24 | $2,489 | $104 |
| Levothyroxine | 131 | $2,187 | $17 |
| Gabapentin | 88 | $1,976 | $22 |
| Pantoprazole | 92 | $1,799 | $20 |
| Lisinopril | 173 | $1,627 | $9 |
| Metoprolol | 89 | $1,530 | $17 |
| Fluticasone Propionate | 63 | $1,467 | $23 |
| Potassium Chloride | 29 | $1,445 | $50 |
| Nano 2nd Gen Pen Needle | 11 | $1,424 | $129 |
| Diclofenac | 17 | $1,336 | $79 |
| Benazepril | 53 | $1,280 | $24 |
| Allopurinol | 61 | $1,265 | $21 |
| Hydrocodone-Acetaminophen | 63 | $1,203 | $19 |
| Bupropion Xl | 21 | $1,141 | $54 |
| Omeprazole | 69 | $1,085 | $16 |
| Metformin | 105 | $1,062 | $10 |
| Zolpidem | 98 | $1,055 | $11 |
| Trazodone | 64 | $999 | $16 |
| Pravastatin | 49 | $998 | $20 |
| Quetiapine | 32 | $983 | $31 |
| Simvastatin | 95 | $968 | $10 |
| Colchicine | 12 | $795 | $66 |
| Atenolol | 70 | $784 | $11 |
| Metformin Hcl Er | 46 | $771 | $17 |
| Finasteride | 36 | $709 | $20 |
| Sertraline | 45 | $683 | $15 |
| Celecoxib | 13 | $661 | $51 |
| Alendronate | 34 | $643 | $19 |
| Donepezil | 55 | $618 | $11 |
| Ciclopirox | 12 | $617 | $51 |
| Lovastatin | 44 | $558 | $13 |
| Hydrochlorothiazide | 73 | $554 | $8 |
| Oxycodone-Acetaminophen | 14 | $553 | $39 |
| Lactulose | 19 | $548 | $29 |
| Valsartan-Hydrochlorothiazide | 12 | $526 | $44 |
| Famotidine | 22 | $508 | $23 |
| Valsartan | 16 | $502 | $31 |
| Azelastine | 13 | $497 | $38 |
| Mirtazapine | 23 | $462 | $20 |
| Hydroxyzine | 29 | $443 | $15 |
| Sumatriptan | 13 | $442 | $34 |
| Hydrocortisone | 22 | $430 | $20 |
| Warfarin | 14 | $423 | $30 |
| Hydromorphone | 11 | $416 | $38 |
| Prednisone | 36 | $408 | $11 |
| Terazosin | 17 | $406 | $24 |
| Oxybutynin Chloride Er | 17 | $397 | $23 |
| Lorazepam | 21 | $393 | $19 |
| Memantine | 14 | $390 | $28 |
| Olmesartan Medoxomil | 23 | $387 | $17 |
| Fluoxetine | 25 | $367 | $15 |
| Carvedilol | 24 | $366 | $15 |
| Amoxicillin-Clavulanate Potass | 41 | $365 | $9 |
| Bupropion Hcl Sr | 14 | $362 | $26 |
| Eszopiclone | 14 | $353 | $25 |
| Pioglitazone | 14 | $339 | $24 |
| Furosemide | 48 | $338 | $7 |
| Clopidogrel | 17 | $334 | $20 |
| Albuterol Sulfate Hfa | 15 | $331 | $22 |
| Triamcinolone Acetonide | 29 | $329 | $11 |
| Doxazosin Mesylate | 15 | $318 | $21 |
| Baclofen | 12 | $318 | $27 |
| Valacyclovir | 15 | $312 | $21 |
| Buspirone | 20 | $309 | $15 |
| Paxlovid (Eua) | 31 | $307 | $10 |
| Losartan-Hydrochlorothiazide | 14 | $304 | $22 |
| Metoprolol | 34 | $303 | $9 |
| Chlorthalidone | 18 | $298 | $17 |
| Nystatin | 20 | $291 | $15 |
| Nitrofurantoin Mono-Macro | 19 | $240 | $13 |
| Glipizide Er | 16 | $238 | $15 |
| Propranolol | 12 | $235 | $20 |
| Escitalopram | 18 | $218 | $12 |
| Azithromycin | 39 | $207 | $5 |
| Cephalexin | 20 | $203 | $10 |
| Citalopram Hbr | 20 | $202 | $10 |
| Lisinopril-Hydrochlorothiazide | 28 | $174 | $6 |
| Montelukast | 12 | $171 | $14 |
| Glipizide | 15 | $170 | $11 |
| Meloxicam | 13 | $160 | $12 |
| Cyclobenzaprine | 15 | $159 | $11 |
| Sildenafil Citrate | 16 | $127 | $8 |
| Naproxen | 13 | $118 | $9 |
| Tramadol | 17 | $96 | $6 |
| Sulfamethoxazole-Trimethoprim | 14 | $69 | $5 |
| Ciprofloxacin | 13 | $50 | $4 |
| Vitamin D2 | 11 | $28 | $3 |
2022: 80 drugs
| Jardiance | 23 | $39,665 | $1,725 |
| Eliquis | 25 | $39,381 | $1,575 |
| Januvia | 18 | $27,053 | $1,503 |
| Novolin 70-30 Flexpen | 11 | $5,308 | $483 |
| Atorvastatin | 316 | $3,735 | $12 |
| Tamsulosin | 118 | $3,094 | $26 |
| Celecoxib | 28 | $2,181 | $78 |
| Losartan | 147 | $2,163 | $15 |
| Levothyroxine | 109 | $1,958 | $18 |
| Gabapentin | 62 | $1,953 | $31 |
| Amlodipine Besylate | 224 | $1,765 | $8 |
| Fluticasone Propionate | 53 | $1,601 | $30 |
| Pantoprazole | 81 | $1,576 | $19 |
| Lidocaine | 12 | $1,496 | $125 |
| Diltiazem | 11 | $1,450 | $132 |
| Lisinopril | 143 | $1,402 | $10 |
| Synthroid | 11 | $1,400 | $127 |
| Albuterol Sulfate Hfa | 21 | $1,364 | $65 |
| Oxybutynin Chloride Er | 13 | $1,330 | $102 |
| Potassium Chloride | 31 | $1,268 | $41 |
| Rosuvastatin | 61 | $1,250 | $20 |
| Metoprolol | 54 | $1,144 | $21 |
| Allopurinol | 47 | $1,127 | $24 |
| Nano 2nd Gen Pen Needle | 16 | $1,112 | $69 |
| Diclofenac | 21 | $1,047 | $50 |
| Hydrocodone-Acetaminophen | 51 | $979 | $19 |
| Colchicine | 12 | $968 | $81 |
| Propranolol | 12 | $899 | $75 |
| Bupropion Xl | 14 | $871 | $62 |
| Simvastatin | 100 | $844 | $8 |
| Atenolol | 64 | $830 | $13 |
| Pravastatin | 45 | $824 | $18 |
| Omeprazole | 44 | $823 | $19 |
| Trazodone | 47 | $779 | $17 |
| Zolpidem | 79 | $714 | $9 |
| Metformin | 83 | $694 | $8 |
| Famotidine | 21 | $638 | $30 |
| Sertraline | 41 | $591 | $14 |
| Valsartan | 19 | $583 | $31 |
| Mirtazapine | 15 | $573 | $38 |
| Benazepril | 31 | $553 | $18 |
| Losartan-Hydrochlorothiazide | 26 | $547 | $21 |
| Hydroxyzine | 14 | $542 | $39 |
| Lovastatin | 41 | $526 | $13 |
| Paxlovid (Eua) | 47 | $476 | $10 |
| Donepezil | 47 | $475 | $10 |
| Hydrocortisone | 23 | $472 | $21 |
| Finasteride | 33 | $436 | $13 |
| Carbidopa-Levodopa | 13 | $431 | $33 |
| Carvedilol | 24 | $405 | $17 |
| Alendronate | 24 | $400 | $17 |
| Lisinopril-Hydrochlorothiazide | 27 | $387 | $14 |
| Metoprolol | 41 | $380 | $9 |
| Quetiapine | 20 | $372 | $19 |
| Metformin Hcl Er | 29 | $350 | $12 |
| Warfarin | 21 | $348 | $17 |
| Bupropion | 15 | $347 | $23 |
| Fluoxetine | 23 | $339 | $15 |
| Hydrochlorothiazide | 62 | $334 | $5 |
| Pregabalin | 12 | $329 | $27 |
| Lactulose | 12 | $320 | $27 |
| Buspirone | 14 | $314 | $22 |
| Lorazepam | 24 | $312 | $13 |
| Sildenafil Citrate | 34 | $297 | $9 |
| Furosemide | 35 | $251 | $7 |
| Glipizide Er | 13 | $237 | $18 |
| Sumatriptan | 11 | $209 | $19 |
| Amoxicillin-Clavulanate Potass | 17 | $209 | $12 |
| Nystatin | 15 | $207 | $14 |
| Terazosin | 11 | $196 | $18 |
| Cyclobenzaprine | 15 | $185 | $12 |
| Nitrofurantoin Mono-Macro | 12 | $157 | $13 |
| Triamcinolone Acetonide | 11 | $156 | $14 |
| Meloxicam | 12 | $140 | $12 |
| Escitalopram | 15 | $136 | $9 |
| Azithromycin | 17 | $123 | $7 |
| Glipizide | 19 | $107 | $6 |
| Citalopram Hbr | 19 | $102 | $5 |
| Prednisone | 17 | $81 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $66 | $5 |
2021: 57 drugs
| Eliquis | 13 | $19,703 | $1,516 |
| Flovent Hfa | 11 | $5,563 | $506 |
| Atorvastatin | 184 | $2,391 | $13 |
| Losartan | 94 | $1,698 | $18 |
| Gabapentin | 42 | $1,451 | $35 |
| Tamsulosin | 68 | $1,441 | $21 |
| Levothyroxine | 65 | $1,400 | $22 |
| Potassium Chloride | 31 | $1,273 | $41 |
| Amlodipine Besylate | 137 | $1,199 | $9 |
| Omeprazole | 49 | $1,104 | $23 |
| Fluticasone Propionate | 36 | $986 | $27 |
| Pantoprazole | 51 | $959 | $19 |
| Latanoprost | 14 | $930 | $66 |
| Colchicine | 15 | $922 | $61 |
| Hydrocodone-Acetaminophen | 60 | $888 | $15 |
| Nano 2nd Gen Pen Needle | 14 | $881 | $63 |
| Rosuvastatin | 31 | $793 | $26 |
| Duloxetine | 16 | $659 | $41 |
| Lisinopril | 64 | $633 | $10 |
| Atenolol | 47 | $605 | $13 |
| Valsartan | 12 | $601 | $50 |
| Trazodone | 41 | $600 | $15 |
| Terazosin | 12 | $585 | $49 |
| Oxycodone-Acetaminophen | 12 | $580 | $48 |
| Lorazepam | 16 | $553 | $35 |
| Lovastatin | 41 | $547 | $13 |
| Metoprolol | 26 | $546 | $21 |
| Allopurinol | 22 | $534 | $24 |
| Finasteride | 23 | $504 | $22 |
| Zolpidem | 51 | $471 | $9 |
| Simvastatin | 53 | $459 | $9 |
| Benazepril | 31 | $459 | $15 |
| Metformin | 59 | $458 | $8 |
| Sertraline | 37 | $430 | $12 |
| Pravastatin | 23 | $420 | $18 |
| Fentanyl | 11 | $409 | $37 |
| Hydromorphone | 11 | $379 | $34 |
| Carvedilol | 20 | $326 | $16 |
| Hydrochlorothiazide | 51 | $323 | $6 |
| Losartan-Hydrochlorothiazide | 14 | $304 | $22 |
| Lisinopril-Hydrochlorothiazide | 18 | $301 | $17 |
| Metformin Hcl Er | 17 | $294 | $17 |
| Ropinirole | 11 | $274 | $25 |
| Warfarin | 12 | $272 | $23 |
| Quetiapine | 13 | $267 | $21 |
| Fluoxetine | 12 | $254 | $21 |
| Furosemide | 34 | $253 | $7 |
| Valacyclovir | 13 | $251 | $19 |
| Oxycodone | 11 | $245 | $22 |
| Donepezil | 20 | $232 | $12 |
| Metoprolol | 22 | $214 | $10 |
| Cyclobenzaprine | 19 | $204 | $11 |
| Buspirone | 20 | $191 | $10 |
| Prednisone | 19 | $186 | $10 |
| Alendronate | 15 | $151 | $10 |
| Nystatin | 11 | $141 | $13 |
| Glipizide | 11 | $86 | $8 |
2020: 28 drugs
| Hydrocodone-Acetaminophen | 49 | $1,426 | $29 |
| Lorazepam | 14 | $1,328 | $95 |
| Atorvastatin | 68 | $1,126 | $17 |
| Losartan | 66 | $906 | $14 |
| Oxycodone-Acetaminophen | 11 | $884 | $80 |
| Levothyroxine | 22 | $706 | $32 |
| Tamsulosin | 19 | $636 | $33 |
| Hydromorphone | 15 | $589 | $39 |
| Terazosin | 19 | $503 | $26 |
| Omeprazole | 16 | $469 | $29 |
| Gabapentin | 17 | $418 | $25 |
| Finasteride | 16 | $404 | $25 |
| Lovastatin | 18 | $323 | $18 |
| Amlodipine Besylate | 39 | $290 | $7 |
| Zolpidem | 36 | $239 | $7 |
| Trazodone | 24 | $228 | $10 |
| Sertraline | 20 | $212 | $11 |
| Hydrochlorothiazide | 43 | $207 | $5 |
| Lisinopril | 22 | $174 | $8 |
| Nystatin | 11 | $171 | $16 |
| Simvastatin | 18 | $169 | $9 |
| Atenolol | 13 | $156 | $12 |
| Benazepril | 12 | $126 | $11 |
| Carvedilol | 19 | $114 | $6 |
| Cyclobenzaprine | 17 | $104 | $6 |
| Famotidine | 12 | $99 | $8 |
| Metformin | 12 | $81 | $7 |
| Clonazepam | 12 | $77 | $6 |
Money from drug and device companies
$415 in 2021
| 2021 | 2 | 9 | None | $415 |
| 2019 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biohaven Pharmaceuticals | Nurtec Odt | $256 | 2 payments
|
| DePuy Synthes Sales | Conduit | $159 | 7 payments
|
See all 9 published payments
| Biohaven Pharmaceuticals | Meals · 2021-10-06 | Nurtec Odt | $100 |
| DePuy Synthes Sales | Meals · 2021-06-19 | Fibergraft Bg Morsels | $15 |
| DePuy Synthes Sales | Meals · 2021-06-11 | Conduit | $40 |
| Biohaven Pharmaceuticals | Meals · 2021-06-04 | Nurtec Odt | $156 |
| DePuy Synthes Sales | Meals · 2021-05-14 | Viper | $27 |
| DePuy Synthes Sales | Meals · 2021-05-04 | Symphony | $32 |
| DePuy Synthes Sales | Meals · 2021-03-12 | Viper | $7 |
| DePuy Synthes Sales | Meals · 2021-03-09 | Vivigen Mis Delivery System | $5 |
| DePuy Synthes Sales | Meals · 2021-03-05 | Vivigen Mis Delivery System | $32 |
See earlier years (2019)
2019: $22
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $22 | 1 payment
|
Professional record
- NPI
- 1134581341
- Licence
- CA A153472California A153472: Current · expires 2027-11-30
- Trained
- New York University School of Medicine, 2016
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-03-26
- NPI last updated
- 2019-09-09
This is when the NPI record was last certified, not a medical board exam.